CD177 and cancer: AuNPs provide long-term imaging and monitoring of target cells since they have a longer circulation time, allow easy modification with ligands that are recognized by cancer cell surface receptors, and experience increased uptake through receptor-mediated endocytosis (RME) as compared to contrast agents currently used in the clinical field [100,101,102].